Umbralisib antagonizes multidrug resistance in ABCB1-overexpressing cancer cells
Letao Bo, Bohan Zhang, Xuan-Yu Chen, Xuanming Mao, Luke Zhong, Meizi Tan, Mingyu Cui, Harsh Patel, John N. D. Wurpel, Zhe-Sheng Chen · 2026
Read Umbralisib antagonizes multidrug resistance in ABCB1-overexpressing cancer cells by Letao Bo, Bohan Zhang, Xuan-Yu Chen, Xuanming Mao, Luke Zhong, Meizi Tan, Mingyu Cui, Harsh Patel, John N. D. Wurpel, Zhe-Sheng Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13518197.txt.
Description
IntroductionABCB1-mediated multidrug resistance (MDR) reduces the intracellular accumulation of anticancer drugs and limits chemotherapy efficacy. This study investigated whether umbralisib, a dual PI3Kδ/CK1ϵ inhibitor, could reverse ABCB1-mediated MDR.MethodsThe reversal effect of umbralisib was evaluated in ABCB1-overexpressing drug-selected and transfected cell models using MTT assays.
Catalog record
| CREATOR | Letao Bo, Bohan Zhang, Xuan-Yu Chen, Xuanming Mao, Luke Zhong, Meizi Tan, Mingyu Cui, Harsh Patel, John N. D. Wurpel, Zhe-Sheng Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |